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Received August 28, 2012; accepted December 21, 2012AbstractBackground: Patient-controlled epidural analgesia (PCEA) is commonly used to relieve postoperative pain for upper abdominal surgeries.
However, there is still a lack of studies exploring factors associated with PCEA consumption over time after upper abdominal surgery; our study
intended to provide further elucidation about this issue.
Methods: This study retrospectively evaluated postoperative PCEA consumption over time after upper abdominal surgery. Cumulative PCEA
consumption in the first four 12-hour intervals was directly retrieved from the data recorded by infusion pumps. Potentially influential factors of
PCEA requirements, including demographic variables and infusion pump settings, were also collected. A linear mixed model was applied to
investigate the relationships between these factors and PCEA consumption over time. A backward elimination strategy was used to select
independent factors significantly associated with PCEA consumption.
Results: A total of 1001 patients were included in the analysis. On average, PCEA consumption after upper abdominal surgery peaked during the
2nd 12-hour interval and then decreased gradually over time. After the model selection processes were completed, four independent factors were
identified to have significant effects on PCEA consumption. Surgery for malignant disease and background infusion rate were positively
associated with PCEA consumption and did not interact with time. Additionally, female patients tended to consume less and less PCEA over
time relative to males. Age had a negative effect on PCEA consumption, which peaked during the 2nd 12-hour interval and then decreased
gradually over time. The final selected model exhibited acceptable predictive power relative to the observed data.
Conclusion: Our analyses provided valuable information about the factors associated with PCEA consumption over time after upper abdominal
surgery. However, the mechanism of how these factors interact over the course of time awaits further investigation.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Postoperative pain management promotes patient comfort,
improves postoperative outcome, and can be regarded as one
of the most important parts of perioperative care.1e5 Patient-
controlled epidural analgesia (PCEA) has been effectively
used for postoperative pain management for decades.6 It ap-
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http://dx.doi.org/10.1016/j.jcma.2013.05.003advantage of better analgesia,7e10 fewer side effects and less
complications,3,10 reduced suppression of lymphocyte prolif-
eration, as well as attenuation of the proinflammatory cytokine
response in the postoperative period.11 Many studies have
demonstrated that, compared with postoperative intravenous
patient-controlled analgesia (IVPCA), PCEA has vigorous
benefits and superior analgesic effects,7,12,13 particularly after
upper abdominal and thoracic surgery.12e14 Mann et al12 have
reported that after major abdominal surgery in elderly patients,
PCEA using local anesthetics and an opioid provided better
pain relief and improved mental status and bowel activity than
IVPCA. Meierhenrich et al14 also demonstrated that in pa-
tients undergoing lung surgery, PCEA is superior to IVPCAhinese Medical Association. All rights reserved.
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pulmonary function.
Nevertheless, there are still some risks involved with
PCEA, such as catheter-associated neurological complications
and potential respiratory depression, hypotension, and motor
blockade, which may compromise postoperative mobilization
or delay patient recovery.10,15,16 These side effects are
considered to be principally attributable to skill technique
problems, drug overdose, and drug interactions.10 In order to
avoid these drawbacks, judicious determination and adjust-
ment of PCEA dosage during the course of administration is
essential. Although some studies had investigated factors
associated with postoperative PCEA demand,17e20 there is still
a lack of studies that examine how these factors interact with
time on PCEA demand, particularly in patients receiving
upper abdominal surgery. Accordingly, this retrospective study
aimed to investigate PCEA consumption over time after upper
abdominal surgery and explore how influential factors of
PCEA consumption interacted with time. A more compre-
hensive picture of and dynamic features involved with the
relationships between PCEA consumption over time and its
influential factors could be provided through our analyses.
2. Methods
After the approval of our institutional review board was
obtained (VGHIRB No.: 2011-03-037-IC), this retrospective
study was conducted at Taipei Veterans General Hospital,
Taipei, Taiwan. Data were collected from patients receiving
PCEA after upper abdominal surgery with laparotomy from
2007 to 2009. Those who had unstable postoperative condition
or major complications and used PCEA for less than 48 hours
owing to miscellaneous causes were eliminated from the
analysis. A 20-gauge epidural catheter was placed at a selec-
tive lower thoracic intervertebral space using an 18-gauge
Tuohy needle and a loss-of-resistance technique to most
effectively identify the epidural space prior to surgery. The
depth of implanted epidural catheters in the epidural space
ranged from 5 cm to 8 cm along the patient’s back. All
epidural catheters were securely affixed with skin adhesive,
tested for loss of sensation in corresponding dermatomes with
2 mL of 2% lidocaine, and further preclude the possibility of
intrathecal or intravascular migration prior to surgery. All
patients received endotracheal intubation under combined
general and epidural anesthesia with epidural loading dose of
10 mL bupivacaine (0.25%) and fentanyl (5 mg/mL) mixture.
Anesthesia was maintained with inhalation anesthetics and
additional epidural bolus doses of 0.25% bupivacaine. After
the completion of surgery, a patient-controlled infusion pump
(Aim Plus system; Abbott Laboratories, North Chicago, IL,
USA) was used to deliver the standardized PCEA infusate
composed of bupivacaine (0.0625%) and fentanyl (1 mg/mL).
The pump settings included a background infusion rate be-
tween 3 mL/h and 7 mL/h, a patient-controlled bolus dose of
1.5e4 mL, and a lockout interval of 15e30 minutes. In order
to ensure data quality, cumulative doses of the first four 12-
hour intervals were calculated using the recordings directlyretrieved from the infusion device. Pain relief was assessed
indirectly by the demand/delivery (D/D) ratio, and values less
than 2 usually imply adequate analgesia.21 Other collected
variables included patient gender, age, weight, height, body
mass index (BMI), and confirmation of surgery for malignant
disease of the stomach, pancreas, gall bladder, or liver (coded
as 0 for nonmalignancy and 1 for malignancy).2.1. Statistical analysisContinuous data are expressed as mean with standard de-
viation, and categorical data are presented as count with per-
centage. The D/D ratios are exhibited as median with
interquartile range (IQR). Linear mixed models with first-
order autoregressive covariance structure were used to eval-
uate within-subject time effects and other between-subject
effects on PCEA consumption over time. A random intercept
model was also used to account for the unexplained variance
at the subject level. The candidate factors consisted of patient
characteristics, including gender, age, height, weight, BMI,
and surgery for malignant disease, and PCEA pump settings,
including bolus dose, background infusion rate, and lockout
interval. The effects of these factors interacting over time were
also examined. A stepwise backward elimination strategy
based on likelihood ratio change was used to select factors and
interaction effects significantly associated with PCEA con-
sumption over time. Scatter plots for predicted PCEA con-
sumption from the selected model against observed PCEA
consumption during different time intervals were illustrated,
and corresponding correlation coefficients were calculated to
check the goodness of fit to data. The Bonferroni adjustment
was used for multiple comparisons, and a p value less than
0.05 was considered statistically significant. According to Peat
and Barton,22 the minimum number of cases for multiple
regression analysis should be at least 100. This criterion was
met because the sample size of this study was 1001. All sta-
tistical analyses were conducted using the SPSS 18.0 (SPSS
Inc., Chicago, IL, USA).
3. Results
A total of 1001 patients were included in our analysis. The
baseline characteristics of the recruited patients are presented
in Table 1. Among them, female patients accounted for nearly
one-third of the study population. The mean age was 63.3
years, and 82.2% of these patients received upper abdominal
surgery for a malignant disease. With respect to the PCEA
pump settings, the mean bolus dose, background infusion rate,
and lockout interval were 2.2 mL, 5.0 mL, and 20.5 min,
respectively. A significant difference in the mean PCEA
consumption during the first four 12-hour intervals was noted
( p < 0.001, linear mixed model analysis). When compared
with the mean PCEA consumption during the 1st 12-hour
interval, more PCEA solution was consumed during the 2nd
12-hour interval ( p ¼ 0.039), but less PCEA consumption
was noted during the 3rd and 4th 12-hour intervals (both
p < 0.001). The D/D ratios of the first four 12-hour intervals
Table 1
Baseline characteristics of patient receiving upper abdominal surgery.
n (%) Mean SD
Gender
Female 325 (32.5)
Male 676 (67.5)
Age (y) 63.3 14.7
Height (cm) 163.6 33.5
Weight (kg) 63.2 19.5
BMI (kg/m2) 23.7 3.6
Malignancy a 823 (82.2)
Bolus dose (mL) 2.2 0.8
Infusion rate (mL/h) 5.0 0.6
Lockout interval (min) 20.5 3.0
PCEA consumption (mL)
0e12 h 74.2 17.4
12e24 h 75.5 19.2
24e36 h 70.1 18.2
36e48 h 69.9 18.0
BMI ¼ body mass index; PCEA ¼ patient-controlled epidural analgesia;
SD ¼ standard deviation.
a Patients received surgery for malignant disease.
Table 3
Effects of selected factors on patient-controlled epidural analgesia (PCEA)
demand over time using a backward model selection strategy.
b SE p
Time <0.001
Time1 (12e24 vs. 0e12 h) 5.62 2.27 0.013
Time2 (24e36 vs. 0e12 h) 4.80 2.24 0.032
Time3 (36e48 vs. 0e12 h) 10.20 2.43 0.000
Age 0.23 0.04 <0.001
Gender (female vs. male) 0.72 1.21 0.549
Malignancy 3.23 1.20 0.007
Rate 9.49 0.89 <0.001
Interaction of Time1 and age 0.05 0.03 0.105
Interaction of Time2 and age 0.03 0.03 0.414
Interaction of Time3 and age 0.11 0.04 0.002
Interaction of Time1 and gender 2.79 1.05 0.008
Interaction of Time2 and gender 2.84 1.04 0.006
Interaction of Time3 and gender 3.85 1.13 0.001
b ¼ regression coefficients estimated from linear mixed model analysis;
SE ¼ standard error of the estimated regression coefficients.
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(IQR ¼ 1.09e2) and 1.5 (IQR ¼ 1e2.12).
The effects of factors included in the analysis on PCEA
consumption after upper abdominal surgery over time are
presented in Table 2. Most factors included in the analysis had
significant effects on PCEA consumption, except lockout in-
terval. Female gender and older age were negatively associ-
ated with PCEA consumption over time, but the other
significant factors (including height, weight, BMI, surgery for
malignant disease, and bolus dose and infusion rate of PCEA
pump) were positively related to PCEA consumption after
upper abdominal surgery. With respect to the interaction effect
of candidate factors on PCEA consumption with time, only
gender ( p ¼ 0.003), age ( p < 0.001), height ( p ¼ 0.019), and
infusion rate ( p ¼ 0.035) had a significant interaction with
time on PCEA consumption after upper abdominal surgery.
Table 3 shows the final results of the model selection pro-
cesses using a backward elimination strategy. On average, the
time effect was still significant, and PCEA consumption after
upper abdominal surgery peaked during 12e24 hours andTable 2
Estimated main effects of miscellaneous factors on patient-controlled epidural
analgesia (PCEA) consumption over time.
b SE p
Gender (female vs. male) 2.92 1.04 0.005
Age 0.34 0.03 <0.001
Height 0.04 0.01 0.003
Weight 0.11 0.02 <0.001
BMI 0.68 0.14 <0.001
Malignancy 3.80 1.27 0.003
Bolus dose 2.10 0.64 0.001
Infusion rate 12.19 0.74 <0.001
Lockout interval 0.17 0.17 0.300
b ¼ regression coefficients estimated from linear mixed model analysis;
BMI ¼ body mass index; PCEA ¼ patient-controlled epidural analgesia;
SE ¼ standard error of the estimated regression coefficients.gradually decreased over time thereafter. Four patient factors
were kept in the final model, and two of the factors (gender
and age) had significant interaction with the time interval
(both p ¼ 0.001). Female gender tended to consume less and
less PCEA solution over time relative to their male counter-
parts. However, there was no significant difference in PCEA
consumption between female and male patients during the 1st
12-hour interval. The age effect resulted in the greatest dif-
ference in PCEA consumption after upper abdominal surgery
during the 2nd 12-hour intervals. Afterward, the difference in
PCEA consumption gradually diminished. Note that the age
effect on PCEA consumption during the 2nd and 3rd 12-hour
intervals was not significantly different from that during the
1st 12-hour intervals. Both surgery for malignant disease and
background infusion rate were positively associated with
PCEA consumption, and their relationships did not seem to
change over time.
Fig. 1 illustrates the scatter plots for predicted PCEA
consumption from the selected model against observed PCEA
consumption during different time intervals. The correlation
coefficients between the observed and predicted PCEA con-
sumption after upper abdominal surgery during the 1st, 2nd, 3rd,
and 4th 12-hour intervals were 0.80, 0.88, 0.84, and 0.87,
respectively, which implied an acceptable predictive power of
the selected model.
4. Discussion
Although PCEA had been shown to be an efficient clinical
technique for postoperative pain management,8,9 there was
still wide variability in the effectiveness of the analgesic effect
from patient to patient. Many factors may influence the PCEA
efficiency and patient satisfaction. These factors include the
anatomical variations, position of epidural catheter, drugs of
regimen (different local anesthetics with or without opioids),
and patient individual factors (such as age, gender, and
height).17,19 Although influential factors for total PCEA
consumption had been inspected,17e20 there is still a lack of
Fig. 1. Scatter plots for predicted patient-controlled epidural analgesia (PCEA) consumption from the selected model against observed PCEA consumption during
different time intervals. The predicted PCEA consumption was close to the real PCEA consumption during the four different time intervals.
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demand over time. Our study aimed to fill this gap by inves-
tigating how potentially influential factors interacted with time
on PCEA demand after upper abdominal surgery. In the pre-
vious study, findings about the relationships between de-
mographic characteristics and total PCEA consumption in
different types of surgery provided several implications for
further study.19 Surgical site is an important influential factor
of PCEA demand and patients receiving different types of
surgery tended to have different demographic characteristics.
In other words, the difference in surgical sites is a major
source of heterogeneity that may result in discrepancy in
PCEA demand. To reduce the uncertainty from heterogeneous
patient groups, we focused on patients receiving upper
abdominal surgery to determine the factors that influence
PCEA consumption over time.
According to our analysis, PCEA consumption after upper
abdominal surgery peaked during the 2nd 12-hour interval and
then decreased gradually over time. In general, the mostintense pain occurred in the first few days after surgery.23,24 It
is reasonably considered that because of the residual anes-
thetic effects, postoperative pain may not reach the maximal
level until the 1st 12-hour after surgery. Afterward, the surgical
pain would become more intense and the patients might de-
mand more analgesic as a result of the subsiding effects of
residual anesthetics. The maximal postoperative pain occurred
during the 2nd 12-hour period, and PCEA consumption cor-
responded to the pain intensity. Our results demonstrated how
the PCEA demand of patients receiving upper abdominal
surgery changed over time.
In our study, it is noted that demographic factors that
affected PCEA demand included patient gender, age, surgery
for malignant disease, and infusion rate of PCEA. Although
we identified that female patients consumed less PCEA solu-
tion than their male counterparts, there is still controversy
in the literature about gender bias in PCEA consumption.19
A recent large-scale study revealed that women consumed
less PCEA solution and had higher pain scores than men.18
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small and not clinically relevant. Gender-related differences in
pharmacokinetic and pharmacodynamic handling of analge-
sics or discrepancy in cognitive pain perception may play
some role in gender bias in PCEA consumption.25,26 We also
found that age negatively correlated with postoperative
IVPCA use. Most studies that investigated change in the
physiology, pharmacodynamics, pharmacokinetics, and pro-
cessing of nociceptive information that occurs with aging may
influence the effectiveness of PCEA and those drugs required
to minimize discomfort, and there is a clinically significant
reduction in the intensity of pain perception with geriatric
patients.27 Surgery for malignant disease was considered to be
a routine pathway for greater surgical damage with a greater
extent or likelihood of severe pain, and was also associated
with elevated PCEA consumption. In a previous study with
170 patients, a correlation between PCEA requirement and
individual characteristics among gynecologic patients was
investigated, which showed that patients undergoing pro-
cedures for malignant diseases consumed more PCEA solution
than those with benign diseases.20 Such results were consistent
with our findings. In addition, we also found that the PCEA
infusion rate directly influenced PCEA demand, and this
finding is compatible with other reports in the literature.28
Although the correlation between lockout interval and pa-
tients’ satisfaction had been investigated in previous
studies,29,30 there was no significant impact on PCEA
requirement with the difference in lockout interval.
There are several limitations in this study. First, the retro-
spective nature of this study limited the data available for
analysis, and had potential problems such as selection and
misclassification bias. Second, only patients receiving upper
abdominal surgery and postoperative PCEA were included in
this study, so the generalization of our findings to other sur-
gical types awaits further investigations. Third, the surgical
types were not further classified and analyzed as a potential
covariate of PCEA demand. Only the factor “malignancy” was
used in the analysis. The classification of surgical type can be
considered in future analyses on PCEA demand over time
whenever the sample size is sufficient.
In conclusion, our analyses provided valuable information
about the factors associated with PCEA consumption over time
after upper abdominal surgery. PCEA consumption peaked
during the 2nd 12-hour interval and then decreased gradually
over time. Female gender and older age were negatively
associated with PCEA consumption, whereas surgery for ma-
lignant disease and background infusion rate were positively
associated with PCEA consumption. Our study demonstrated
the interaction effects of gender and age with time on PCEA
demand. Female patients tended to use less and less PCEA over
time relative to male patients. Age had a negative effect on
PCEA consumption, which peaked during the 2nd 12-hour in-
terval and then decreased gradually over time. These findings
may provide potential implications in clinical practice as de-
terminants of PCEA pump settings or guides to dose adjust-
ment during the PCEA course. PCEA consumption analysis
over time provides a more comprehensive view and dynamicfeatures of the relationships between PCEA consumption and
its influential factors. However, further investigation is required
to unveil the underlying mechanisms and validate our predic-
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